Stocks and Investing Stocks and Investing
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $210 on, Aug 23rd, 2022


Published on 2024-10-27 22:47:14 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $180 to $210 on, Aug 23rd, 2022.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $55 on, Wednesday, August 10th, 2022


These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022